https://de.marketscreener.com/kurs/aktie/KNIGHT-THERAPEUTICS-INC-15925497/news/Knight-Therapeutics-schlie-t-exklusive-Lizenzvereinbarung-mit-Supernus-Pharmaceuticals-fur-Qelbree-45604324/?utm_source=telegram&utm_medium=social&utm_campaign=share